Exane Derivatives’s United States Brent Oil Fund BNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-79
Closed -$2.36K 818
2022
Q1
$2.36K Buy
+79
New +$2.11K ﹤0.01% 741
2021
Q4
Sell
-79
Closed -$1.63K 891
2021
Q3
$1.63K Sell
79
-3,211
-98% -$60.9K ﹤0.01% 818
2021
Q2
$64.8K Sell
3,290
-49,098
-94% -$862K 0.01% 607
2021
Q1
$832K Sell
52,388
-35,108
-40% -$538K 0.24% 93
2020
Q4
$1.13M Sell
87,496
-23,955
-21% -$272K 0.33% 71
2020
Q3
$1.19M Sell
111,451
-58,517
-34% -$657K 0.34% 62
2020
Q2
$1.83M Buy
169,968
+100,768
+146% +$921K 0.49% 66
2020
Q1
$546K Buy
+69,200
New +$1.12M 0.15% 115

Other funds holding BNO

Exane Derivatives's BNO Position: Q2 2022 in Review

Exane Derivatives sold out of United States Brent Oil Fund (BNO) in Q2 2022, closing a stake of 79 shares — an estimated $2.36K sold.

Exane Derivatives first reported a position in BNO in Q1 2020 and held it in 8 quarters. The position peaked at $1.83M in Q2 2020. 52 funds tracked by Wall St. Rank hold BNO as of Q2 2022.

  • Exane Derivatives reported no remaining United States Brent Oil Fund position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 79 United States Brent Oil Fund shares in Q2 2022, an estimated $2.36K.
  • Exane Derivatives first reported a position in United States Brent Oil Fund in Q1 2020 and held it in 8 quarters.
  • Exane Derivatives's United States Brent Oil Fund position peaked at $1.83M in Q2 2020.
  • 52 funds tracked by Wall St. Rank held United States Brent Oil Fund as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.